Biotech Analyst Shi, along with Dr. Gartrell, Director of GU Oncology at Montefiore Einstein Cancer Center, will discuss the urothelial cancer treatment landscape with focus on Nectin-4 agents, including PADCEV and clinical candidate BT8009, on an Analyst/Industry conference call to be held on February 10 at 3 pm. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BCYC:
